SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-009782
Filing Date
2017-05-22
Accepted
2017-05-22 15:29:44
Documents
1
Period of Report
2017-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3354
  Complete submission text file 0001437749-17-009782.txt   5009
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 12270 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
PLUMB RUSSELL H (Reporting) CIK: 0001283216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 17860768